News releases - Merck.com
Oct 28, 2024 · Find the latest news from Merck & Co., Inc., a global biopharmaceutical company, on its official website. Browse news releases by year, category, or keyword and see the most recent updates on clinical trials, approvals, acquisitions, and more.
Merck Announces Third-Quarter 2024 Financial Results
Oct 31, 2024 · Merck's worldwide sales were $16.7 billion, up 4% from Q3 2023, driven by KEYTRUDA, WINREVAIR and CAPVAXIVE. Non-GAAP EPS was $1.57, down 26% from Q3 2023, due to business development transactions and lower sales of GARDASIL/GARDASIL 9.
Merck Announces Fourth-Quarter and Full-Year 2023 Financial …
Feb 1, 2024 · Merck announced financial results for the fourth quarter and full year of 2023, with worldwide sales of $60.1 billion, up 1% from 2022. The company reported sales growth of 19% for KEYTRUDA, 29% for GARDASIL/GARDASIL 9, and 12% …
News & Stories - Merck
Oct 9, 2024 · Find out the latest news from Merck, a global science and technology company, and stay updated with its upcoming events. Learn more about its strategy, values, sustainability, and diversity.
Merck Enters Two Strategic Collaborations to Strengthen AI …
Sep 20, 2023 · Merck, a leading science and technology company, enters into strategic collaborations with BenevolentAI and Exscientia to generate novel clinical development candidates in oncology, neurology and immunology. The partnerships leverage AI-driven design and discovery capabilities to accelerate and enhance R&D productivity and output.
Merck Launches First Ever AI Solution to Integrate Drug Discovery …
Dec 5, 2023 · Merck introduces AIDDISON™, a software-as-a-service platform that combines generative AI, machine learning and computer-aided drug-design to speed up drug development. The platform virtually...
Merck raises 2024 profit forecast on surging sales of cancer drug ...
Apr 25, 2024 · Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda, the world's top selling prescription...
Merck: promising results from Koselugo study - MarketScreener
1 day ago · Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (67%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc ...
Merck Rallies to Best Year Since 1995 on Strong Sales, Drug Data
Dec 30, 2022 · Merck & Co. notched its best yearly gain in more than two decades, making it the top-performing drugmaker in the S&P 500 in 2022 as investors rewarded the company for strong earnings and upbeat...
Merck sees Gardasil China woes carrying into 2025 - Yahoo Finance
Oct 31, 2024 · (Reuters) -Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's distributor there reduces inventories amid low demand, and the U.S ...